Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $19.67, but opened at $20.80. Ascentage Pharma Group International shares last traded at $21.20, with a volume of 39,891 shares traded.
Ascentage Pharma Group International Stock Up 7.6 %
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
- Five stocks we like better than Ascentage Pharma Group International
- The Risks of Owning Bonds
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How to invest in marijuana stocks in 7 stepsÂ
- DuPont’s Electronics Spinoff: The Start of Something Big
- High Dividend REITs: Are They an Ideal Way to Diversify?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
